Publication
Keeping your dawn raid guidance current
Unannounced inspections or ‘dawn raids’ are used by antitrust authorities to obtain evidence when there are suspicions that individuals or businesses have infringed the antitrust rules.
Health industry organizations that receive state funds have been grappling in recent years with efforts by New York Governor Andrew Cuomo, and by the Department of Health (DOH), to limit the amount of compensation paid to their executives.
Following the issuance of a 2012 Executive Order by the Governor, the enactment of regulations by DOH limiting the compensation permitted to be paid to health industry executives, several actions were filed challenging the regulations. Two of those cases were consolidated at the Supreme Court level—In the Matter of LeadingAge New York, Inc. v. Shah and In the Matter of Coalition of New York State Public Health Plans v. New York State Department of Health (collectively, LeadingAge). LeadingAge reached the Court of Appeals, which on Oct. 18, 2018 struck down a critical prohibition contained in the regulations.
This article analyzes how the New York legal landscape has evolved with respect to compensation paid to health industry executives, and the state of the law in light of the Court of Appeals’ ruling in LeadingAge.
Publication
Unannounced inspections or ‘dawn raids’ are used by antitrust authorities to obtain evidence when there are suspicions that individuals or businesses have infringed the antitrust rules.
Publication
The EU Foreign Subsidies Regulation, or FSR, is intended to prevent or remedy distortions of the EU internal market caused by “foreign” – meaning non-EU – subsidies benefitting companies active in the EU.
Publication
The English High Court has given its judgment in the legal battle between FW Aviation (FWA) and VietJet Aviation Joint Stock Company (VietJet). This case revolved around the enforcement of leasing agreements for four Airbus aircraft and the alleged interference by VietJet in the aircraft’s repossession in Vietnam.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023